Angioimmunoblastic T-Cell Lymphoma Treatment News and Symptoms Information

What is Angioimmunoblastic T-Cell Lymphoma (AITL)?

(Symptoms, Causes & Treatment)

According to the University of Michigan Health System, Angioimmunoblastic T-cell lymphoma (AITL) is a rare form of non-Hodgkin lymphoma, which is a group of related malignancies (cancers) that affect the lymphatic system (lymphomas). The lymphatic system functions as part of the immune system and helps to protect the body against infection and disease. The lymphatic system consists of a network of tubular channels (lymph vessels) that drain a thin watery fluid known as lymph from different areas of the body into the bloodstream.

The Lymphoma Research Foundation states that while AITL only accounts for one to two percent of all NHL cases in the United States, it is one of the more common subtypes of mature T-cell lymphomas. Elderly patients are more likely to have AITL.

Symptoms of AITL can include high fever, night sweats, skin rash, and autoimmune disorders such as autoimmune hemolytic anemia (AIHA) and immune thrombocytopenia (ITP). As a result of these autoimmune disorders, the body’s immune system attacks its own cells and tissues, such as red blood cells (AIHA) or platelets (ITP).


See below for updated news and information regarding Angioimmunoblastic T-Cell Lymphoma including new medical research, treatment options and advancements. 

Latest Angioimmunoblastic T-Cell Lymphoma Treatment News and Research

No recent news regarding Angioimmunoblastic T-Cell Lymphoma is available. 

healthcare careers

science careers

If you have experience dealing with this disease or condition (especially with regard to symptoms, diagnosis, causes or treatment), please share below: